Urol. praxi. 2025;26(3):156-163 | DOI: 10.36290/uro.2025.073

Prevention of urinary tract infections in patients with urinary catheters

MUDr. Aleš Čermák, Ph.D.1, 2, 3, MUDr. Jakub Papirek1, MUDr. Natálie Čurdová1
1 Urologická klinika Fakultní nemocnice, Brno
2 Lékařská fakulta Masarykovy univerzity, Brno
3 Chirurgické oddělení Vojenské nemocnice, Brno

Urinary tract infections (UTIs) are among the most common bacterial infections. UTIs are the second most common infectious disease in the population, following upper respiratory tract infections. UTIs also represent one of the most common nosocomial infections. They are a common complication associated with urinary tract catheteri­zation (CAUTI), especially during long-term catheterization or catheterization related to the endoscopic procedures. The most effective way to prevent CAUTI is to avoid unnecessary or inproperly indicated catheterization.

Modern medicine must repeatedly seek new strategies for prophylaxis before invasive procedures and for the treatment of UTIs, with particular attention to the reasing prevalence of bacterial resistance and the frequent overuse of unindicated antibiotic therapy. This article aims to evaluate the current evidence on the prevalence, risk factors, and preventive measures related to infection during urinary catheterization.

Keywords: urinary tract infection, urinary catheter, antimicrobial therapy, healthcare-associated infection, risk factors, prevention.

Accepted: September 29, 2025; Published: October 17, 2025  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Čermák A, Papirek J, Čurdová N. Prevention of urinary tract infections in patients with urinary catheters. Urol. praxi. 2025;26(3):156-163. doi: 10.36290/uro.2025.073.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Purchase PDF - 60 CZK (2.5 EUR)
    will be unlocked 17.10.2026

    References

    1. Zhao AO T, Du G, Zhou X. Inappropriate urinary catheterisation: a review of the prevalence, risk factors and measures to reduce incidence. Br J Nurs. 2022;31(9):S4-S13. Go to original source... Go to PubMed...
    2. Čemák A. Současné možnosti léčby infekcí dolních cest močových. Urol. praxi. 2024;25(3):114-120. Go to original source...
    3. Kohoutová J. Uroinfekce spojené se zdravotní péčí - epidemiologie, prevence. Urol. praxi. 2014;15(1):30-31.
    4. Levison ME, Kaye D. Treatment of complicated urinary tract infections with an emphasis on drug-resistant gram-negative uropathogens. Curr Infect Dis Rep. 2013;15(2):109-115. Go to original source... Go to PubMed...
    5. Bonkat G, Wagenlehner F, Cai T, et al. Classification of Urinary Tract Infections in 2025: Moving Beyond Uncomplicated and Complicated. Eur Urol Open Sci. 2025;75:44-47. Go to original source... Go to PubMed...
    6. European Association of Urology. EAU Guidelines on Urological infections. Edn. presented at the EAU Annual Congress Madrid 2025. Arnhem: EAU, 2025. ISBN 978-94-92671-29-5.
    7. Johansen TE, Botto H, Cek M, et al. Critical review of current definitions of urinary tract infections and proposal of an EAU/ESIU classification system. Int J Antimicrob Agents, 2011; 38 Suppl: 64. Go to original source... Go to PubMed...
    8. Sammon JD, Sharma P, Rahbar H, et al. Predictors of admission in patients presenting to the emergency department with urinary tract infection. World J Urol. 2014;32(3):813-819. Go to original source... Go to PubMed...
    9. Kakaria BA, Ashish K, Tushar R. Study of incidence and risk factors of urinary tract infection in catheterised patients admitted at tertiary care. Int J Res Med Sci. 2018;6(5). Go to original source...
    10. Daniels KR, Lee GC, Frei CR. Trends in catheter-associated urinary tract infections among a national cohort of hospitalized adults, 2001-2010. Am J Infect Control. 2014;42(1):17-22. Go to original source... Go to PubMed...
    11. Nicolle LE. Catheter-associated urinary tract infections. Antimicrob Resist Infect Control. 2014;3:23. Go to original source... Go to PubMed...
    12. Flores-Mireles AL, Pinkner JS, Caparon MG, et al. EbpA vaccine antibodies block binding of Enterococcus faecalis to fibrinogen to prevent catheter-associated bladder infection in mice. Sci Transl Med. 2014;6(254):254ra127. Go to original source... Go to PubMed...
    13. Flores-Mireles AL, Walker JN, Bauman TM, et al. Fibrinogen release and deposition on urinary catheters placed during urological procedures. J Urol. 2016;196(2):416-421. Go to original source... Go to PubMed...
    14. Ministerstvo zdravotnictví ČR. Národní ošetřovatelský postup - Katetrizace močového měchýře: Věstník Ministerstva zdravotnictví České republiky 2020, roč. 2020;2:121-128. ISSN: 1211-0868.
    15. Weiner LM, Webb AK, Limbago B, et al. Antimicrobial-resistant pathogens associated with healthcare-associated infections: Summary of data reported to the national healthcare safety network at the Centers for Disease Control and Prevention, 2011-2014. Infect Control Hosp Epidemiol. 2016;37(11):1288-1301. Go to original source... Go to PubMed...
    16. Walker JN, Flores-Mireles AL, Pinkner CL, et al. Catheterization alters bladder ecology to potentiate Staphylococcus aureus infection of the urinary tract. Proc Natl Acad Sci USA. 2017;114(41):E8721-E8730. Go to original source... Go to PubMed...
    17. Guiton PS, Hannan TJ, Ford B, et al. Enterococcus faecalis overcomes foreign body-mediated inflammation to establish urinary tract infections. Infect Immun. 2013;81(1):329-339. Go to original source... Go to PubMed...
    18. Nielsen HV, Flores-Mireles AL, Kau AL, et al. Pilin and sortase residues critical for endocarditis- and biofilm-associated pilus biogenesis in Enterococcus faecalis. J Bacteriol. 2013;195(19):4484-4495. Go to original source... Go to PubMed...
    19. Colomer-Winter C, Flores-Mireles AL, Baker SP, et al. Manganese acquisition is essential for virulence of Enterococcus faecalis. PLoS Pathog. 2018;14(9):e1007102. Go to original source... Go to PubMed...
    20. Crosby HA, Kwiecinski J, Horswill AR. Staphylococcus aureus aggregation and coagulation mechanisms, and their function in host-pathogen interactions. Adv Appl Microbiol. 2016;96:1-41. Go to original source... Go to PubMed...
    21. Mittal R, Sharma S, Chhibber S, et al. Iron dictates the virulence of Pseudomonas aeruginosa in urinary tract infections. J Biomed Sci. 2008;15(6):731-741. Go to original source... Go to PubMed...
    22. Newman JW, Floyd RV, Fothergill JL. The contribution of Pseudomonas aeruginosa virulence factors and host factors in the establishment of urinary tract infections. FEMS Microbiol Lett. 2017;364(15). Go to original source... Go to PubMed...
    23. Tamura NK, Gasparetto A, Svidzinski TI. Evaluation of the adherence of Candida species to urinary catheters. Mycopathologia. 2003;156(4):269-272. Go to original source... Go to PubMed...
    24. Bizoňová J, Jarošová D. Vliv preventivních strategií na vznik infekce močových cest při katetrizaci močového měchýře. Cent Eur J Nurs Midw. 2011;2(3):257-263.
    25. Armbruster CE, Mobley HLT, Pearson MM. Pathogenesis of Proteus mirabilis Infection. EcoSal Plus. 2018 Feb;8(1):10.1128/ecosalplus.ESP-0009-2017. Go to original source... Go to PubMed...
    26. Mody L, Greene MT, Meddings J, et al. A national implementation project to prevent catheter-associated urinary tract infection in nursing home residents. JAMA Intern Med. 2017;177(8):1154-1162. Go to original source... Go to PubMed...
    27. Centers for Disease Control and Prevention (CDC). Směrnice pro prevenci infekce močového traktu v souvislosti s použitím katétru. CDC Guideline for Prevention of Catheter-Associated Urinary Tract Infections [online]. 2009 [cit. 2025-09-05]. Dostupné z: http://www.cdc.gov/hicpac/pdf/CAUTIguideline2009final.pdf.
    28. Gould CV, Umscheid CA, Agarwal RK, et al. Healthcare Infection Control Practices Advisory Committee. Guideline for prevention of catheter-associated urinary tract infections 2009. Infect Control Hosp Epidemiol. 2010;31(4):319-326. Go to original source... Go to PubMed...
    29. Stickler DJ. Bacterial biofilms in patients with indwelling urinary catheters. Nat Clin Pract Urol. 2008;5(11):598-608. Go to original source... Go to PubMed...
    30. Pickard R, Lam T, Maclennan G, et al. Types of urethral catheter for reducing symptomatic urinary tract infections in hospitalised adults requiring short-term catheterisation: Multicentre randomised controlled trial and economic evaluation of antimicrobial- and antiseptic-impregnated urethral catheters (the CATHETER trial) Health Technol Assessment. 2012;16(47):1-197. Go to original source... Go to PubMed...
    31. Ortega M, Marco F, Soriano A, et al. Epidemiology and prognostic determinants of bacteraemic catheter-acquired urinary tract infection in a single institution from 1991 to 2010. J Infect. 2013;67(4):282-287. Go to original source... Go to PubMed...
    32. Flores-Mireles AL, Walker JN, Potretzke A, et al. Antibody-based therapy for enterococcal catheter-associated urinary tract infections. mBio. 2016;7(5):e01653-16. Go to original source... Go to PubMed...

    Return to the content


    Urology for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.